To everyone who posted so far on this thread: you might want to read both the DNA "Preliminary Final Report" (especially EBITDA for Star Vegas on pg 12, 2nd column) as well as HC discussion of EBITDA, FCF, and debt on the "FY2016 Results Summary" thread. Those posts (mine excluded) offer what appears to be more accurate and professional analysis of these results. Sorry.
To everyone who posted so far on this thread: you might want to...
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $40.76M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.3¢ | 3.3¢ | $16.70K | 506.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 282103 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 753993 | 3 |
View Market Depth
| Last trade - 11.17am 12/06/2024 (20 minute delay) ? |
|
|||||
|
Last
3.3¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 3.3¢ | 3.3¢ | 3.3¢ | 75492 | ||
| Last updated 11.17am 12/06/2024 ? | |||||
| DNA (ASX) Chart |